Enter your login e-mail to the account
Search
- The benefit of lenalidomide in the treatment of patients with newly diagnosed multiple myeloma
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Richard Jusko, MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, MUDr. Lenka Lisá, PhD., MUDr. Ivana Plameňová, PhD., MBA
(1/2025, Drugs & drug classes ) - Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - Brentuximab vedotin for the treatment of patients with Hodgkin lymphoma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. Anna Chbat, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD., Prof. MUDr. Ján Staško, PhD.
(1/2022, Drugs & drug classes )
- Inhibitors of factors XI and XII
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. František Nehaj, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Lenka Lisá, PhD., MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, Prof. MUDr. Ján Staško, PhD.
(1/2024, Review articles )